Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes

OBJECTIVE: To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. RESEARCH DESIGN AND METHODS: Forty-one obese women (aged 48 ± 11 years and BMI 33.1 ± 4.1 kg/m(2)) participated in a 35-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Dushay, Jody, Gao, Chuanyun, Gopalakrishnan, Gosala S., Crawley, Meghan, Mitten, Emilie K., Wilker, Elissa, Mullington, Janet, Maratos-Flier, Eleftheria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241299/
https://www.ncbi.nlm.nih.gov/pubmed/22040840
http://dx.doi.org/10.2337/dc11-0931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241299/
https://www.ncbi.nlm.nih.gov/pubmed/22040840
http://dx.doi.org/10.2337/dc11-0931

Ejemplares similares